Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
March 01 2017 - 6:59AM
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global
medical technology company, today announced that it was awarded a
contract worth up to $100 million with the Defense Health Agency
(DHA) under the U.S. Department of Defense (DoD) for its Pyxis™ ES
System. Under the purchase agreement, BD will provide its
enterprise-wide medication dispensing technology platform across
the DHA’s 115 military inpatient health facilities and military
inpatient pharmacies.
“Through this collaboration with the DoD, we have the
opportunity to help modernize the DHA’s medication management and
dispensing systems across all of the organization’s facilities in
the United States, Asia and Europe,” said Ranjeet Banerjee,
worldwide president of Medication Management for BD. “We are
honored to expand our longstanding partnership with the
organization, to both upgrade existing legacy Pyxis sites to an
enterprise-wide solution, as well as expand our footprint across
all DHA facilities.”
Key solution areas include:
- The Pyxis ES System’s Automated Dispensing Cabinet (ADC) meets
the highest quality standards for implementation at military
treatment facilities across the Military Health System
- Proven pharmacy inpatient automation solution with flexibility
to handle multiple architecture configurations supporting
decentralized deployments
- Flexibility to consolidate configurations and scale the system
via a centralized enterprise-wide platform
- Secure storage of medication and pharmaceutical items
- Provides automated system administration with tracking and
management of medications
- Provides advanced data analytics and reporting
capabilities
- Supports industry standard interface and integration
capabilities and compatibilities
Under the terms of the agreement, BD will provide its industry
leading Pyxis ES System consisting of Pyxis™ Enterprise Server,
Pyxis MedStation™ ES system, Pyxis™ Smart CUBIE™ technology,
and integrated analytics tools – the Knowledge Portal for Pyxis™
medication technologies. This contract award is contemplated in the
company’s fiscal year 2017 guidance.
The Pyxis ES System is a scalable, web-based platform
specifically designed to improve medication management across the
continuum of care. The Pyxis ES platform promotes a patient-centric
health care model, leveraging HIT system and Active Directory
integration to enable a single health system formulary, simplified
identity management and workflow enhancements. The platform enables
pharmacists to manage medications remotely and eliminate redundant
tasks. Nurses can readily access secured medications using safe and
simple workflows that are centered on the patient.
For more information about the Pyxis Enterprise Solution, please
visit: http://www.carefusion.com/pyxis.
About BDBD is a global medical technology
company that is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. BD leads in
patient and health care worker safety and the technologies that
enable medical research and clinical laboratories. The company
provides innovative solutions that help advance medical research
and genomics, enhance the diagnosis of infectious disease and
cancer, improve medication management, promote infection
prevention, equip surgical and interventional procedures, and
support the management of diabetes. The company partners with
organizations around the world to address some of the most
challenging global health issues. BD has more than 40,000
associates across 50 countries who work in close collaboration with
customers and partners to help enhance outcomes, lower health care
delivery costs, increase efficiencies, improve health care safety
and expand access to health. For more information on BD, please
visit bd.com.
Contacts:
Matt Coppola
BD Public Relations
201.847.7370
matthew_r_coppola@bd.com
Monique N. Dolecki
BD Investor Relations
201.847.5378
monique_dolecki@bd.com
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Sep 2023 to Sep 2024